Table 2.
Association between serum cotinine and ASMI.
| Outcome | Model 1 | Model 2 | Model 3 | |||||
|---|---|---|---|---|---|---|---|---|
| β (95%CI) | P-value | β (95%CI) | P-value | β (95%CI) | P-value | |||
| Cotinine (ng/mL) | 0.000 (-0.000, 0.001) | 0.07990 | -0.001 (-0.001, -0.000) | < 0.00001 | -0.001 (-0.001, -0.001) | < 0.00001 | ||
| Cotinine (tertiles) | ||||||||
| Q1 | Reference | Reference | Reference | |||||
| Q2 | 0.150 (0.060, 0.240) | 0.00107 | 0.158 (0.082, 0.234) | 0.00005 | 0.028 (-0.080, 0.136) | 0.60821 | ||
| Q3 | 0.241 (0.152, 0.330) | < 0.00001 | -0.003 (-0.079, 0.073) | 0.93640 | -0.135 (-0.264, -0.007) | 0.03845 | ||
| P for trend | < 0.001 | 0.02 | 0.01 | |||||
Model 1: no covariates were adjusted. Model 2: age, gender and race were adjusted. Model 3: age, gender, race, FIPR, WBC, hemoglobin, glycohemoglobin, albumin, globulin, AST, iron, uric acid, creatinine, HDL, LDL, total Cholesterol, triglyceride, vitamin D, hypertension, diabetes, and smoking status were adjusted